Prices delayed by at least 15 minutes | Print
Gsk PLC (GSK)
ORD 31 1/4POpen
1,370.00p
Previous close
1,362.00p
Trade high
1,389.00p
Volume
11,614,773
Year high
1,823.50p
Year low
1,242.50p
Dividend yield
4.48%
Market capitalisation
£55.88 bn
P/E ratio
21.90
ISIN
GB00BN7SWP63
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Dividends
Previous | Latest | |
---|---|---|
Record date | 15/11/2024 | 21/02/2025 |
Ex-dividend date | 14/11/2024 | 20/02/2025 |
Payment date | 09/01/2025 | 10/04/2025 |
Amount | 15.00p | 16.00p |
Company profile
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
23/04/2025 | 04:16:08 | 1383 | 0 | 0.00 |
23/04/2025 | 04:12:46 | 1382.5 | 0 | 0.00 |
23/04/2025 | 04:05:26 | 1383.5 | 0 | 0.00 |
23/04/2025 | 03:42:57 | 1384.5 | 0 | 0.00 |
23/04/2025 | 03:40:41 | 1385.5 | 0 | 0.00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.